Status of antituberculosis drug resistance in Saudi Arabia 1979-98

Eastern Mediterranean Health Journal

Volumn 8, Issue 4-5, 2002, Pages 664-670

  Abu Amero, K K ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATION; EXTRAPULMONARY TUBERCULOSIS; GEOGRAPHIC DISTRIBUTION; HEALTH CARE POLICY; HUMAN; LUNG TUBERCULOSIS; MEDICAL LITERATURE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POPULATION RESEARCH; PREVALENCE; PUBLISHING; REVIEW; SAUDI ARABIA; STANDARDIZATION; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EPIDEMIOLOGY, MOLECULAR; HUMANS; MICROBIAL SENSITIVITY TESTS; POPULATION SURVEILLANCE; PREVALENCE; RESEARCH DESIGN; RESIDENCE CHARACTERISTICS; SAUDI ARABIA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 10644282058     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Dye C et al. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. Journal of the American Medical Association, 1999, 282(7): 677-86.
2. Willcox PA. Drug-resistant tuberculosis: worldwide trends, problems specific to Eastern Europe and other hotspots, and the threat to developing countries. Current opinion in pulmonary medicine, 2001, 7(3):148-53.
3. Espinal MA et al. Global trends in resistance to antituberculosis drugs. World Health Organization, International Union against Tuberculosis and Lung Disease Working Group on Anti-tuberculosis Drug Resistance Surveillance. New England journal of medicine, 2001, 344(17):1294-303.
4. Cohn DL, Bustreo F, Raviglione MC. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. Clinical infectious diseases, 1997, 24 (suppl.1):S121-30.
5. Pablos-Mendez A et al. Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization, International Union against Tuberculosis and Lung Disease Working Group on Anti-tuberculosis Drug Resistance Surveillance. New England journal of medicine, 1998, 338(23):1641-9.
6. Anti-tuberculosis drug resistance in the world. Report 2: Prevalence and trends. Global project on anti-tuberculosis drug resistance surveillance. Geneva, World Health Organization, 2000:1-253 (document WHO/CDS/TB/2000.278).
7. Schwoebel V et al. Standardization of anti-tuberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group. European respiratory journal, 2000, 16(2):364-71.
8. Al-Rubaish AM, Madania AA, Al-Muhanna FA. Drug resistance pulmonary tuberculosis in the Eastern Province of Saudi Arabia. Saudi medical journal, 2001, 22(9):776-9.
9. Wali S et al. Multi-drug resistant tuberculosis. Saudi medical journal, 1998, 19: 802-6.
10. Al-Orainey IO et al. Resistance to antituberculosis drugs in Riyadh, Saudi Arabia. Tubercle, 1989, 70(3):207-10.
11. Shanks NJ et al. Tuberculosis in Saudi Arabia. Saudi medical journal, 1983, 4:151-6.
12. Schiott CR et al. Incidence of drug resistance amongst isolates of Mycobacterium tuberculosis recovered in Gizan area, Saudi Arabia. Saudi medical journal, 1985, 6:375-8.
13. Jarallah JS et al. High rate of rifampicin resistance of Mycobacterium tuberculosis in the Taif region of Saudi Arabia. Tubercle and lung disease, 1992, 73(2): 113-5.
14. Al-Orainey IO. Resistance to standard antituberculous drugs in Saudi Arabia. Saudi medical journal, 1989, 7:363-8.
15. Al-Rasheed AM et al. Low prevalence of multi-drug resistance tuberculosis in Saudi patients: an eleven-year retrospective study. A refereed abstract presented at the 20th Annual Congress of the European Society of Mycobacteriology, Lucerne, Switzerland, 1999.
16. Ellis ME et al. High proportion of multidrug resistant Mycobacterium tuberculosis in Saudi Arabia. Scandinavian journal of infectious diseases, 1996, 28(6):591-5.
17. Zaman R. Tuberculosis in Saudi Arabia: initial and secondary drug resistance among indigenous and non-indigenous populations. Tubercle, 1991, 72(1):51-5.
18. Kinsara A et al. Review of tuberculosis at the King Khalid National Guard Hospital, Jeddah, Saudi Arabia. Saudi medical journal 1997, 19:212-4.
19. Khan MY et al. Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia. International journal of antimicrobial agents, 2001, 17:415-8.
20. Milaat WA et al. Epidemiology of tuberculosis in Jeddah region, Saudi Arabia. Saudi medical journal, 1994, 15:133-7.
21. Al-Zaeer A et al. Tuberculosis is the commonest cause of pneumonia requiring hospitalization during Hajj (pilgrimage to Makkah). Journal of infection, 1998, 36:303-6.
22. Al-Kassimi FA et al. Nationwide community survey of tuberculosis epidemiology in Saudi Arabia. Tubercle and lung disease 1993, 74(4):254-60.
23. Al-Hajjaj MS, Al-Khatim IM. High rate of non-compliance with anti-tuberculosis treatment despite a retrieval system: a call for implementation of directly observed therapy in Saudi Arabia. International journal of tuberculosis and lung disease, 2000, 4(4):345-9.
24. Al-Kassimi FA. Review of tuberculosis in Saudi Arabia. Saudi medical journal, 1994, 15:192-5.
25. Rifai E. Tuberculosis in Arab countries. Saudi medical journal, 1982, 1:86-91.